多发性硬化症患者群体中脱节症的患病率:系统性审查和元分析
Vassiliki Smyrni1, Vasileios Giannopapas2, Dimitrios K Kitsos1
1Second Department of Neurology, National and Kapodistrian University of Athens, Greece.
Multiple sclerosis and related disorders
|April 23, 2025
概括
发病症影响了近一半多发性硬化症 (MS) 患者. 这次审查没有发现脱节性关节症和多发性硬化症疾病因素之间的联系,强调需要更好地跟踪症状.
科学领域:
- 神经学 神经学
- 语言病理学 语音病理学
背景情况:
- 发病症是一种运动语言障碍,经常在患有多发性硬化症 (PwMS) 的人群中观察到.
- 现有的研究显示患病率为40-51%,但缺乏关于其与疾病进展或持续时间相关性的一致证据.
研究的目的:
- 系统地审查和分析PwMS. dysarthria在PwMS中的患病率.
- 调查多发性硬化症与人口统计学/疾病特异性因素之间的潜在联系.
主要方法:
- 在MEDLINE PubMed,Cochrane图书馆和Scopus上进行了系统的文献搜索.
- 遵守PRISMA指导方针进行审查和元分析.
- 包括14项研究,1833名多发性硬化症患者.
主要成果:
- 多发性硬化症的综合患病率为44.9%.
- 与健康对照组相比,多发性硬化症患者的言语障碍风险明显更高 (RR 8.09).
- 难关症与年龄或残疾水平之间没有发现显著的关联;一个不显著的趋势表明与疾病持续时间有相反的关系.
结论:
- 多发性硬化症在多发性硬化症患者中非常普遍 (44.9%).
- 难关症与人口统计学或疾病特异性因素之间没有显著的关联.
- 强调需要在MS中系统地记录失关节症,以改善临床实践和生活质量.
相关概念视频
Parkinson's Disease: Overview
310
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
310
Myasthenia Gravis: Overview and Treatment
958
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
958
Myasthenia Gravis: Diagnostic Tests
538
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
538


